Posted by AGORACOM-JC
at 7:17 PM on Sunday, February 21st, 2021
ORTHO Regenerative Technologies is a cutting-edge med tech firm that uses its proprietary RESTORE technology platform to dramatically improve the success rate of orthopedic and sports medicine surgeries.
In layman’s terms, that means company has a wonder delivery platform that delivers biologics – drugs made from biological processes – to repair soft tissues in the human body.
The technology uses biologics derived from things like plasma and bone marrow concentrate to regenerate new tissue in various musculoskeletal conditions.
This includes Wound Healing, Cartilage repair and Osteo-arthritis
So, how big is the market opportunity for Soft Tissue Repair? At least $5bn in the U.S. alone. This includes:
Rotator Cuff TEAR (which leads to shoulder dysfunction and pain):
4m patients in the U.S. alone
600,000 annual surgeries in the U.S. alone
$600m+ market opportunity
Meniscus Tear Repair (which is painful and compromises knee function):
There are 1.2m surgeries annually in U.S. alone
$1bn+ market opportunity
Cartilage Lesions Repair (this is where lesions cause friction and pain):
1.2m detected lesions annually in U.S. alone
120,000 surgeries and a lack of options
$1bn+ market opportunity
Get comfy for this insightful interview with Claude LeDuc, Ortho’s CEO.
Posted by AGORACOM-JC
at 3:24 PM on Saturday, February 20th, 2021
Game-changing achievement for the budding cannabis enterprise
Received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately
license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor
“Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink
Vancouver, British Columbia–(February 20, 2021) – TransCanna Holdings Inc.(CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately.
The State of California has granted a cultivation license to Lyfted Farms – a TransCanna wholly owned subsidiary – for its flagship Daly facility in Modesto, California. Bob Blink, TransCanna CEO states “Such cultivation licenses in the region are notoriously difficult to obtain. Current applications are back-logged and not even being considered for processing by the county until the end of 2021.”
For TransCanna, the license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor.
“Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink. “Demand has been consistently outstripping supply for our exotic indoor cannabis strains, and now with this new massive facility receiving approval for cultivation, we can finally meet that demand and continue to scale. This will make us one of the largest licensed facilities of its kind in the State of California.”
In addition to cultivation, the new Daly facility empowers TransCanna to increase its scope of offerings and establish its dominance in the California cannabis supply chain.
The Daly facility will anchor other TransCanna operations and serve as a supply chain hub for third party farms across Northern California, offering secure storage, concentrate manufacturing, wholesale market-making, white label services, and State-wide distribution.
Prior to achieving its cultivation license, the facility gained its distribution license in June 2020. Next, TransCanna is eagerly anticipating its processing license (pending approval by the State of California mid to late March) which will qualify the company to dry, cure, trim, grade, and package cannabis onsite. In addition to saving time and money for in-house brands with on-site processing, the processing license will enable TransCanna to open up new revenue streams servicing third party growers.
“California’s cannabis market is $5 billion in sales and growing, and we are well on our way to establishing ourselves at the epicenter of this category with our cultivation, processing, wholesaling and distribution arms of the entire California supply chain,” said Bob Blink, TransCanna CEO.
About TransCanna
TransCanna Holdings Inc. is a California-based, Canadian-listed company building cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.
TransCanna’s wholly owned subsidiary Lyfted Farms is California’s authentic cannabis brand whose pioneering spirit has been continuously providing the finest cannabis flower genetics and cultivation methods since 1984. The Lyfted Farms brand of exclusive cannabis flower is sold at premium retailers throughout the state. With its new cultivation facility in Daly, California, the company is now poised to become one of the largest and most efficient vertically integrated cannabis companies in the California market.
Posted by AGORACOM-JC
at 9:17 AM on Wednesday, February 17th, 2021
Beyond Meat has become an $11 BILLION company by creating products designed to emulate beef.
Non-Alcoholic beer is now an $18 BILLION market by creating products designed to emulate alcoholic beverages.
The basis of success for each has come from delivering the experience meat eaters and beer drinkers have come to love, without any of the negative health effects.
TAAT™ Beyond Tobacco™ mimics the experiences of cigarettes without nicotine or tobacco. It is engineered to closely emulate the sensory components of smoking a tobacco cigarette, including tasting and smelling just like tobacco.
E-cigarettes and vaping have failed despite existing for 15 years, driving most smokers back to cigarettes because they only perpetuate the problem of nicotine addiction while delivering a completely different user experience to smokers.
Under the leadership of experienced veterans from the tobacco industry, including and especially Philip Morris International, TAAT™ launched in the United States just 9 weeks ago and has already received repeat orders from more than 60% of convenience and gas station customers.
How good was this launch?
“Out of all of the tobacco category products I have worked with, TAAT™ is an outlier in terms of the level of demand it has had in its early stages. I have launched dozens of new tobacco brands across Canada as well as in the Caribbean, and while many of the new products were reordered by retailers in their first several weeks on the market, none of them were reordered by anywhere near 60% of stores that initially carried them. …. I have confidence that we could replicate these outcomes both in Ohio and in other markets where we may introduce TAAT™ in the future.” – TAAT Chief Revenue Officer Tim Corkum (former commercialization executive for Philip Morris International)
How big is the market TAAT is going after? Tobacco is used by:
34M adults in America, equating to 215 BILLION cigarettes sold in 2018
1.3 billion people worldwide
… and almost all of them aspire to leave nicotine behind. Beyond Tobacco™ from TAAT is about to give them what they want and, if they succeed, give shareholders “Beyond Belief” returns in the next 2-3 years.
Watch this great interview with CEO Setti Coscarella!
Posted by AGORACOM-JC
at 9:00 AM on Tuesday, February 16th, 2021
Received notice from the City of Pickering regarding an initial inspection of the Company’s proposed cannabis dispensary located at 776 Liverpool Rd., Unit 4, Pickering, Ontario, L1W 1S2.
Spyder Subco has a Retail Operator License issued by the Alcohol and Gaming Commission of Ontario and currently operates a cannabis dispensary in Niagara Falls, Ontario.
Vaughan, Ontario–(February 16, 2021) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“), an established Canadian cannabis and vape retailer, is pleased to announce that its wholly-owned subsidiary, Spyder Cannabis Subco Inc. (“Spyder Subco“), has received notice from the City of Pickering regarding an initial inspection of the Company’s proposed cannabis dispensary located at 776 Liverpool Rd., Unit 4, Pickering, Ontario, L1W 1S2. Spyder Subco has a Retail Operator License issued by the Alcohol and Gaming Commission of Ontario (the “AGCO“) and currently operates a cannabis dispensary in Niagara Falls, Ontario.
In anticipation of the city’s approval of the sale of cannabis in Pickering, the Company secured a retail premises and began to build out the location in 2019. The inspection is scheduled to take place during the week of February 16, 2021. Subject to passing the inspection, and making any necessary modifications, Spyder Subco will be placed in the queue of applications and will await receipt of a Retail Store Authorization from the AGCO for the new premises, permitting the Company to begin operating a licensed cannabis dispensary in Pickering and its second dispensary in Ontario.
Dan Pelchovitz, President & CEO of Spyder, commented, “Pickering is strategically located where Toronto, York and Durham Regions meet, and boasts a growing population of approximately 100,000 residents. Spyder’s team is excited to bring its brand name and best-in-class customer service to one of the fastest growing cities in Ontario.”
Posted by AGORACOM-JC
at 6:35 PM on Monday, February 15th, 2021
Predictmedix $PMED $PMEDF Is What Happens When You Combine Artificial Intelligence With Contactless Screening To Detect Viruses, Impairment And Even Mental Illness.
Predictmedix is an Artificial Intelligence Company that has developed fast, non-invasive, contactless screening devices that detect infectious diseases, impairment and even mental illness at any location where mass amounts of people gather. Specifically, they determine the probability of a person being infected so safety protocols can be initiated.
$PMED screeners are fully automated and intelligent, so they don’t need personnel to operate them.
THE PROBLEM – TEMPERATURE GUNS DON’T HELP DETECT COVID-19
3RD PARTY VALIDATION
More than just lip service, Predictmedix recently partnered with Wellness for Humanity to deploy Safe Entry Stations at the Big Game festivities in Tampa, Florida, ahead of the SuperBowl.
Moreover, they have partnered with some incredible global giants like Tech Mahindra, a multi-billion dollar company with Fortune 500 clients, to be the first to roll out the technology. How big is Tech Mahindra?
Named in the Top 15 Global IT Companies by Forbes
Highest Ranked Non-US company in Forbes Global Digital 100 List (2018)
Named in the Forbes Fab 50 Companies in Asia (2018)
Tech Mahindra will resell $PMED scanners to their entire client base after a successful pilot.
$PMED has even further 3rd party validation and exciting applications for their technology, so make sure to watch this great interview with COO Dr. Rahual Kushwah to learn all about the Company and where it is going.
Posted by AGORACOM-JC
at 4:22 PM on Friday, February 12th, 2021
Our thesis at AGORACOM is that small cap disruptive technology companies are going to create 3X more wealth this decade than the last 3 decades combined, thanks to the convergence of powerful tech such as Artificial Intelligence, IoT sensors and so on.
Why? The costs to develop, deploy and scale new applications powered by these new technologies have come down to a point where small cap companies can compete head to head with just about anybody. In fact, their size makes them more nimble and able to pivot into emerging trends much quicker than most tech giants.
Which companies will actually succeed in delivering is a determination you have to make. But one company to consider is Predictiv AI (PAI:TSXV / INOTF:OTCQB), whose proprietary artificial intelligence and machine learning platform provides predictive and prescriptive solutions in the public safety sector.
In layman’s terms, PAI uses AI and Machine learning to create solutions that can predict danger.
For example, the Company’s Thermal Pass Fever Detection System was recently used at a Carolina Panthers NFL game. Watch this short video to see it in action. Highlights of the system include:
24 medical grade sensors
1,200 readings per second
1 person / second
As you can imagine, Thermal Pass can be used for almost any high-traffic location you can think of. But the big question is …. will anybody actually use it? Because truth be told 99% of us are not in a position to be able to assess how any AI solutions of any company stack up against the competition. The only thing we can rely on is AGORACOM’s favourite metric – 3rd party acceptance. In short, if your product is good, people will want it.
By that measure, PAI is off to a great start with:
Orders for 62 units of ThermalPass since commercial launch in October. Impressive.
Orders include hospitals, long-term care facilities, prisons and public schools. More impressive
6 channel partners. This is really impressive because channel partners don’t waste their valuable time and resources with products they don’t think they can sell
3rd party acceptance at this early stage – CHECK
Watch our interview with Michael Lende in which we do a deep dive into PAI tech, products and future plans.
Tags: AI, Predictiv AI, small cap, small cap stocks, stocks, tsx, tsx-v Posted in Predictiv AI | Comments Off on VIDEO – Predictiv AI $PAI.ca $INOTF Is Already Commercializing Artificial Intelligence Driven Thermal Scanners With 62 Orders and 6 Channel Partners
Posted by AGORACOM-JC
at 6:36 PM on Thursday, February 11th, 2021
AGORACOM followers have given us great feedback on our hit series “Beyond The Press Release” (BTPR) in which we speak with small cap CEO’s about important press releases in greater depth and, quite frankly, in layman’s terms for investors to truly understand their significance.
Nowhere is this more important than in the world of disruptive technologies, biotech and pharma. Each of these industries share two distinct traits:
The possibility for explosive growth with disruptive new products
Difficulty in conveying disruptive new products that, by their nature, have never been seen before by investors.
Whereas BTPR tells these stories from the side of small cap public companies, Beyond The Expert (BTE) tells these stories from the perspective of experts on these topics – and we couldn’t think of anyone better to start off this series than Leigh Hughes.
Leigh is a Venture Capitalist who I’ve personally watched conduct incredible due diligence and invest into many small cap companies that have generated incredible returns over 12-18 month periods.
Leigh is so good at what he does that many global private equity funds and institutions take his call and often follow him into investments he chooses to make. Moreover, he serves as an advisor to several small cap companies.
If you ever wanted to truly learn how to become a great small cap investor, it doesn’t get much better than this.
Without further adieu, watch this great interview with Leigh Hughes and make sure to provide us with your feedback via comments on Twitter, YouTube or wherever you may be watching or listening.
Posted by AGORACOM-JC
at 5:29 PM on Thursday, February 11th, 2021
As the name implies “PropTech” is a combination of two words and stands for “property technology.” As simple as that is, the implementation and importance of PropTech is anything but, which is why many companies are trying to capitalize on the rapidly growing paradigm shift, while Universal PropTech (UPI:TSXV) is actually delivering healthy building solutions developers, owners and operators across Canada.
More than just lip service, UPI clients include
Federal Government facilities for over 40 years
Manulife
Brookfield
Billy Bishop Airport
University of Toronto
…. and many more
As a result, UPI has generated $35,000,000+ in revenue over the past 3 year – a number most small cap companies would be very happy with. But newly appointed Chief Growth Officer, Frank Carnevale sees a much bigger opportunity by winning exclusive licenses and partnerships with providers of great products that can significantly grow company revenues.
And that’s exactly what he has done. In the month of FEBRUARY alone, UPI has announced:
Agreement with LuminUltra Technologies to Provide SARS-CoV-2 (COVID-19) Surface Testing
Channel Partnership with SensorSuite Inc. to Deliver AI Building Automation for MURBs and Non-BAS Customers
Exclusive Distributor Agreement for Eastern Canada for Canadian-Made Air Sanitization Solutions
How significant are these announcements and what do they mean to the Company’s growth?
Watch our interview with CGO Carnevale to learn about these and where UPI is going.
Posted by AGORACOM
at 12:37 PM on Wednesday, February 10th, 2021
School BUSRide spoke with Kevin Moore, CEO of SOBRsafe™, about touch-based alcohol detection and the difference it can make for school transportation
Kevin Moore, Chief Executive Officer, said that for he and SOBRsafe™, child safety represents a chance to make a societal difference with breakthrough technology.
Originally formed by venture capital firm First Capital Ventures, and merged with a detection technology development company, SOBRsafe is at its core a technology and data platform for touch-based alcohol detection – and it is coming to school buses.
“We brought a lot of previously successful people together as the leadership at SOBRsafe,” Moore said. “And one of the key elements for that leadership is to make a difference with this company. We are all at the point in our lives where we want to leave a generational legacy – and child safety is an area where we can make a significant social impact.”
Moore said that American school transportation lacks tools to fully prevent impaired driving, through no fault of the districts and schools themselves. With current capabilities and requirements, alcohol impairment can often go untracked at school bus operations – or tracked with very limited or random screening techniques.
“Every parent treasures their child’s safety,” Moore said, “so we asked ourselves, ‘What if we had a solution that screens 100 percent of bus drivers before they can receive keys and operate a bus?’”
SOBRcheck™
After a lengthy research and development period, SOBRsafe is launching SOBRcheck™ for access control, a patent-pending, proprietary device that provides touch-based identity verification and alcohol detection via a “go/no go” methodology.
When a human ingests alcohol, one of the ways it leaves the body is via transdermal expiration – through the skin. The SOBRcheck™ device does not provide a Blood Alcohol Content (BAC) reading, instead detecting the presence of alcohol in Zero Tolerance situations – like a school bus operation.
The system further functions as a driver/vehicle authenticator by beaming light onto a driver’s skin and creating a set of data points. Those data points then act as that driver’s unique identification. Moore said that this helps alleviate privacy concerns, as the device is not recording fingerprints.
Furthermore, the information that the device collects is immediately transmitted to supervisors via a user-friendly app. This process, Moore said, allows transportation managers, operation managers, and other supervisors to make proactive decisions as opposed to reactive corrections.
“This is the sort of tool which will not only allow school transportation departments to keep children safe, but also provide parents with peace of mind about their child on the bus,” Moore said. “We see preemptive alcohol detection as a critical need for school buses, and feel this device is a phenomenal way to fulfill that need. Systems like this can be essential to ensure that school buses are substance-free environments.”
Kevin Moore, Chief Executive Officer, said that for he and SOBRsafe™, child safety represents a chance to make a societal difference with breakthrough technology.
A unique model
Moore said that SOBRsafe’s intellectual property is currently focused on alcohol detection, but the company is exploring technology centered around detection of cannabis, opioids, and other illicit drugs – as driven by employer need and market demand.
“The key to SOBRsafe is that we are not out developing technologies that require years of testing before commercialization,” Moore said. “We are an integrator of technologies. So, in addition to our internal alcohol detection development, we are looking for other commercially-ready technologies that might work within our system architecture.”
In addition to pursuing other substance detection solutions, Moore said that SOBRsafe is continuing to develop additional value-added features for its devices. The company is launching a new employee health and wellness platform soon, and is implementing GPS location, temperature checks, and more physiology-based technology into its devices for future deployments.
“There is a tremendous amount of emerging technology that can provide a huge benefit for schools and transportation operations,” he said. “We just have to find it, prove its effectiveness, and integrate it into our solutions.”
Deploying to school buses
Moore said that SOBRsafe moved through several prototypes and multiple human trials of the SOBRcheck device, as refining the technology’s various algorithms and detection processes is an exacting, time-consuming task. This was especially so in the wake of the nation’s COVID-19 shutdowns, extending the time required for effective pilot programs.
Once the current round of “production tooling” is complete, the company will launch another pilot program – and then go to market for school districts in the second quarter of 2021.
“We are accelerating the intervention process for school districts,” he said. “Driving under the influence is a serious matter, and intervention can reduce accidents, litigation, deaths, and operating costs.”
More than anything, Moore said, the company’s core objective is safety and saving lives, with child safety at the forefront.
“The feedback we are getting is extremely positive because there is a need in pupil transportation that has not been properly addressed with legacy technology,” Moore said. “When supervisors can proactively make critical decisions by using this data, it is going to improve productivity and save lives.”
Posted by AGORACOM-JC
at 9:51 AM on Tuesday, February 9th, 2021
Entered into an agreement on February 5, 2021 with LuminUltra Technologies Ltd. to deploy their GeneCount Rapid SARS-CoV-2 surface testing solution for UPI’s current and past customers which total over 2,000 facilities including certain aviation assets in Canada today.
The Agreement provides UPI the ability to provide testing services employing LuminUltra’s GeneCount® qPCR tests as a service.
Toronto, Ontario–(February 9, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) is pleased to announce that is has entered into an agreement on February 5, 2021 with LuminUltra Technologies Ltd. (“LuminUltra“) to deploy their GeneCount Rapid SARS-CoV-2 surface testing solution for UPI’s current and past customers which total over 2,000 facilities including certain aviation assets in Canada today. The Agreement provides UPI the ability to provide testing services employing LuminUltra’s GeneCount® qPCR tests as a service.
Chris Hazelton, President and CEO of UPI commented: “We are very excited to bring LuminUltra’shighly reputable SARS-CoV-2 surface testing solution to our customer base in Canada to ensure workplaces are sanitary and safe,” Mr. Hazelton continued: “We had committed strategically to expanding our product mix and investing in key technology to enhance our Trusted Advisor status with our customers. Coupled with our recent announcements, the addition of LuminUltra’s surface testing technology to our suite of services, we are well on our way to meeting that commitment to customers and shareholders.”
UPI’s wholly owned operating subsidiary, VCI Controls, will utilize the LimunUltra GeneCount® qPCR test in order to provide audit support for the efficacy of the various indoor air quality equipment it is installing in customer facilities. In this way, VCI Controls will be able to provide clients with data demonstrating the real world effectiveness of the air sanitization equipment it installs, along with peace of mind for owners and staff alike that Covid-19 is not present in their facilities.
LuminUltra provides testing solutions for clinical diagnostics, surface, and wastewater testing. LuminUltra, through its rapid, accurate and portable qPCR tests help safeguard and protect environments by providing verification of disinfection protocols to confirm the absence of the SARS-CoV-2 virus. This helps identify early warning signs which enables the execution of swift response including contact tracing and human testing.
Fully Portable Manual Testing Using GeneCount® Q-16
